Wearable Medical Technologies for Better Health

Wearable Medical Technologies for Better Health

Photo by Shutterstock

Wearable Medical Technologies for Better Health

Country
Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Technology and Communications
Sub Sector
Most major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Technology
Indicative Return
Describes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
> 25% (in IRR)
Investment Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Medium Term (5–10 years)
Market Size
Describes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
> USD 1 billion
Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.
USD 1 million - USD 10 million
Direct Impact
Describes the primary SDG(s) the IOA addresses.
Good health and well-being (SDG 3) Industry, Innovation and Infrastructure (SDG 9)
Indirect Impact
Describes the secondary SDG(s) the IOA addresses.
Decent Work and Economic Growth (SDG 8)

Business Model Description

Facilitating early action and remote monitoring in health through mobile health applications syncing with wearable devices for better health in monitoring conditions such as diabetes.

Expected Impact

This IOA will facilitate early diagnosis and reduce the pressure on healthcare facilities, contributing positively to health and wellbeing indicators

How is this information gathered?

Investment opportunities with potential to contribute to sustainable development are based on country-level SDG Investor Maps.

Disclaimer

UNDP, the Private Finance for the SDGs, and their affiliates (collectively “UNDP”) do not seek or solicit investment for programmes, projects, or opportunities described on this site (collectively “Programmes”) or any other Programmes, and nothing on this page should constitute a solicitation for investment. The actors listed on this site are not partners of UNDP, and their inclusion should not be construed as an endorsement or recommendation by UNDP for any relationship or investment.

The descriptions on this page are provided for informational purposes only. Only companies and enterprises that appear under the case study tab have been validated and vetted through UNDP programmes such as the Growth Stage Impact Ventures (GSIV), Business Call to Action (BCtA), or through other UN agencies. Even then, under no circumstances should their appearance on this website be construed as an endorsement for any relationship or investment. UNDP assumes no liability for investment losses directly or indirectly resulting from recommendations made, implied, or inferred by its research. Likewise, UNDP assumes no claim to investment gains directly or indirectly resulting from trading profits, investment management, or advisory fees obtained by following investment recommendations made, implied, or inferred by its research.

Investment involves risk, and all investments should be made with the supervision of a professional investment manager or advisor. The materials on the website are not an offer to sell or a solicitation of an offer to buy any investment, security, or commodity, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.

Read More

Country & Regions

Explore the country and target locations of the investment opportunity.
Country
Region
  • Turkey: Eastern Anatolia Region
  • Turkey: Central Anatolia Region
  • Turkey: Southeastern Anatolia Region
Learn more

Sector Classification

Situate the investment opportunity within sustainability focused sector, subsector and industry classifications.
Sector

Technology and Communications

Development need
Technology is a cross-cutting sector for many SDGs. In terms of its performance on SDG 9 (Industry, Innovation and Infrastructure), Turkey faces major challenges. The country performs well-below the global long-term objective in indicators such as Expenditures on Research and Development and the Number of Researchers (per thousand employed people). (1)

Policy priority
The 11th Development Plan, the Sustainable Development Goals Evaluation Report, 2020 Annual Presidential Program and the 2019-2023 Strategy Plan of the Ministry of Industry and Technology all highlight the importance of technology for the achievement of the SDGs and stress the need to digitally transform the country’s economy as a prerequisite for competitive production.

Gender inequalities and marginalization issues
According to the Women in Tech Index, the percentage of female employment in technology is at a mere 9.91% in Turkey. 37.11% of STEM graduates are female. There is a gender pay gap of 8.42% between men and women in the tech industry. This necessitates policies and business models that promote the employment of women in technology with fair wages. (13)

Investment opportunities
The government intends to mobilize investment momentum in this sector. Existing incentives are offered by TUBITAK, KOSGEB, The Ministry of Industry and Technology and the Development and Investment Bank of Turkey. The importance of investing in this sector is increasingly evident with the outbreak of the COVID-19 pandemic, necessitating remote access to vital services

Key bottlenecks
The ability to compete on prices with imported technological products and services already present in the Turkish market; infant-industry problems. Ambiguity of the regulations in some of the latest areas of development such as IoT. Issues related to cyber security and data privacy.

Sub Sector

Technology

Development need
COVID-19 has demonstrated the importance of wearable medical technologies and remote monitoring services for the treatment of high-risk group patients with chronic health conditions.

Policy priority
The production of medical devices and technology are among the priority sectors listed in the 11th Development Plan

Gender inequalities and marginalization issues
According to the Women in Tech Index, the percentage of female employment in technology is at a mere 9.91% in Turkey. 37.11% of STEM graduates are female. There is a gender pay gap of 8.42% between men and women in the tech industry. This necessitates policies and business models that promote the employment of women in technology with fair wages. (13)

Investment opportunities
"The production of medical devices and watches with precision and optical instruments” is among the priority investment areas listed by the Ministry of Trade. As such, they benefit from Region 5 Incentives such as tax reductions and VAT exemptions, credit and insurance support

Key bottlenecks
The ability to compete on prices with imported technological products and services already present in the Turkish market; infant-industry problems.

Industry

Electronic Manufacturing Services and Original Design Manufacturing

Pipeline Opportunity

Discover the investment opportunity and its corresponding business model.
Investment Opportunity Area

Wearable Medical Technologies for Better Health

Business Model

Facilitating early action and remote monitoring in health through mobile health applications syncing with wearable devices for better health in monitoring conditions such as diabetes.

Business Case

Learn about the investment opportunity’s business metrics and market risks.

Market Size and Environment

Market Size (USD)
Describes the value in USD of a potential addressable market of the IOA.

> USD 1 billion

CAGR
Describes the historical or expected annual growth of revenues in the IOA market.

> 25%

The global wearable medical device market size is expected to reach US$93.19 billion by 2027. It is projected to progress at a compound annual growth rate (CAGR) of 27.9% during the forecast period. (7)

Indicative Return

IRR
Describes an expected annual rate of growth of the IOA investment.

> 25%

Interviewed investors already active in the Turkish medical technology sector target an IRR level of 40%.

Investment Timeframe

Timeframe
Describes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.

Medium Term (5–10 years)

Medical devices need clinical and regulatory approval. A major component of this is the regulatory process, which varies based on the risk level of the product. The products also need to be tested and certified by accredited laboratories, separate procedures apply for exports to the EU

Ticket Size

Average Ticket Size (USD)
Describes the USD amount for a typical investment required in the IOA.

USD 1 million - USD 10 million

Market Risks & Scale Obstacles

Capital - CapEx Intensive

High investment costs and the complex processes of medical and regulatory approval might have limited scale up to today.

Impact Case

Read about impact metrics and social and environmental risks of the investment opportunity.

Sustainable Development Need

Wearable technologies incentivizes behavior that reduces hospital visits and re-admissions due to poorly managed personal health.

The COVID-19 pandemic has demonstrated the importance of wearable medical technologies and remote monitoring services for the treatment of high-risk group patients with chronic health conditions.

Gender & Marginalisation

Lack of or reduced access to health access to rural population, women, inmigrants, among others

Women are currently underemployed in the technology sector in Turkey, with only 9.91% of the workforce in this sector being female. This is trend is not solely driven by the lack of female STEM graduates, as 37.11% of STEM graduates in Turkey are female. (13) -continued below

Increased investments and job openings within this sector can help remedy this employment gap. However, it comes down to targetted policy interventions and incentives to promote this initiative. Companies within this business model should be encouraged to hire female STEM graduates.

Expected Development Outcome

Reduce the number of hospital visits and the overall stress on the healthcare system

Adopt proactive measures for disease prevention/intervention and improve outcomes in patient health and well-being

Reduce healthcare costs per patient due to systematic monitoring

Gender & Marginalisation

Reduce health access gaps for rural population, women, inmigrants, among others

This IOA will increase the job opportunities for women and decrease the gender wage gap in the technology sector employment if the appropriate policies are implemented.

Primary SDGs addressed

Good health and well-being (SDG 3)
3 - Good Health and Well-Being

3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease

3.b.2 Total net official development assistance to medical research and basic health sectors

Current Value

16.1% (1)

$2.16 billion (8)

Target Value

9.3% (1)

Industry, Innovation and Infrastructure (SDG 9)
9 - Industry, Innovation and Infrastructure

9.5.1 Research and development expenditure as a proportion of GDP

9.5.2 Researchers (in full-time equivalent) per million inhabitants

Current Value

0.96% (1)

1,156.51 per million people (2015) (8) 4.01 per thousand (1)

Target Value

3.7% (1)

15 per thousand (1)

Secondary SDGs addressed

8 - Decent Work and Economic Growth

Directly impacted stakeholders

People

Patients with chronic health conditions, especially during viral outbreaks to which they might be particularly vulnerable, healthcare professionals, caregivers

Corporates

Medical device producers, private hospitals and healthcare providers

Public sector

Universities, R&D Centers, public healthcare providers, Social Security Institution, public and private payers/insurance providers

Indirectly impacted stakeholders

People

Healthcare practitioners- medical technologies might facilitate diagnosis and increase the accessibility of diagnostics data

Gender inequality and/or marginalization

female, rural, or inmigrant population who lack access to health services

Corporates

Internet service providers

Outcome Risks

Cyber risks: If data transmitted via wearables is not properly secured, companies can face repercussions.

Bodily injury risks: Malfunctioning devices can cause injuries, illnesses and even death of wearers or patients. Device manufacturers may face a product liability lawsuit.

Impact Risks

Execution Risk Efficiency Risk

Impact Classification

C—Contribute to Solutions

What

Important, positive outcome: facilitation of early diagnoses and reduced number of healthcare.

Risk

Medium Risk (Impact might not occur as intended if the devices are not effective. It might potentially cause harm)

Impact Thesis

This IOA will facilitate early diagnosis and reduce the pressure on healthcare facilities, contributing positively to health and wellbeing indicators

Enabling Environment

Explore policy, regulatory and financial factors relevant for the investment opportunity.

Policy Environment

(11th Development Plan): The production of medicine and medical devices are among the priority sectors listed in the 11th Development Plan

(2020 Presidential Program): Pharmaceuticals and medical devices are among the priority sectors listed in the 2020 Presidential Program for their competitive potential in the global market, ability to enhance scientific research throughout the country, improve patient well-being, train and engage with qualified human resources and provide secure employment throughout the country

(2019-2023 Strategic Plan of the Ministry of Health): In the 2019-2023 Strategic Plan of the Ministry of Health constraints within the Turkish health system such as the inefficient use of information technologies, the limited scale of R&D in healthcare throughout the country, and the underemployment of health personnel resulting in an inability to meet service and institutional demands are emphasized

Financial Environment

Financial incentives: TÜBİTAK R&D Projects Support Program. The Ministry of Industry and Technology and The Development and Investment Bank of Turkey established "The Technology and Innovation Fund" under the Turkey Development Fund

Fiscal incentives: The production of medical devices and watches with precision and optical instruments is among the priority investment areas listed by the Ministry of Trade. As such, they benefit from Region 5 Incentives such as tax reductions and VAT exemptions, credit and insurance support

Regulatory Environment

(Regulation): The Official Newspaper issue no. 29001, dated 15th of May 2014, introduced the “Medical Device Sales, Advertisement and Marketing Regulation”

(Regulation): The Social Security Institution, Medicine Refund Regulation and the Alternative Refund Regulation govern reimbursements and the coverage of medical expenses

(Regulation): Law #5746 – Law on Supporting R&D Activities extends the scope of supports and incentives on R&D, innovation and design activities, activities carried out in technology development zones, and decisions by the Council of Ministers

Marketplace Participants

Discover examples of public and private stakeholders active in this investment opportunity that were identified through secondary research and consultations.

Private Sector

In 2017, there were 3,315 firms and 44,667 dealers in total in the medical devices sub-sector of Turkey. Domestic and international banks.

Government

The Ministry of Health & TÜBİTAK & The Ministry of Industry and Technology

Non-Profit

ARTED (Investigative Medical Technology Producers Association), SADER (The Foundation for Medical Equipment Producers and Representatives), SEİS (Turkey Health Industry Employers Union) and TÜMDEF (The Federation for all Medical Device Producer and Supplier Foundations)

Target Locations

See what country regions are most suitable for the investment opportunity. All references to Kosovo shall be understood to be in the context of the Security Council Resolution 1244 (1999)
country static map
urban

Turkey: Eastern Anatolia Region

Eastern Anatolia, parts of Central Anatolia (like Kırşehir and Aksaray) and Southeastern Anatolia Regions demonstrate the lowest number of hospital beds per 100,000 people and lowest number of physicians per 1,000 people (14).
urban

Turkey: Central Anatolia Region

Eastern Anatolia, parts of Central Anatolia (like Kırşehir and Aksaray) and Southeastern Anatolia Regions demonstrate the lowest number of hospital beds per 100,000 people and lowest number of physicians per 1,000 people (14).
urban

Turkey: Southeastern Anatolia Region

Eastern Anatolia, parts of Central Anatolia (like Kırşehir and Aksaray) and Southeastern Anatolia Regions demonstrate the lowest number of hospital beds per 100,000 people and lowest number of physicians per 1,000 people (14).

References

See what sources were used to establish the investment opportunity’s data and find resources that could be consulted to explore more.